טבלאות רגישויות מבית החולים שערי צדק - תרביות דם - Shaare zedek medical center antibiotic sensitivity table - blood cultures
מתוך ויקירפואה
גרסה מ־14:45, 24 בספטמבר 2013 מאת Motyk (שיחה | תרומות) (←טבלה 4 א': Antimicrobial susceptibilities (%) of selected organisms (in alphabetical order), isolated from blood cultures, 2001-2008.)
שם הספר: שימוש מושכל באנטיביוטיקה ונהלים למניעת זיהומים | |
---|---|
![]() | |
שם המחבר | פרופ' עמוס ינון, פרופ' יחיאל שלזינגר, דר' דוד רווה |
שם הפרק | טבלאות רגישויות מבית החולים שערי צדק - תרביות דם - Shaare zedek medical center antibiotic sensitivity table - blood cultures |
מוציא לאור | |
מועד הוצאה | תשע"א – 2010 |
מספר עמודים | 196 |
הקדשה | ספר זה מוקדש לפרופ' חיים הרשקו בהוקרה עמוקה |
טבלה 1. Number (%) of positive blood cultures/drawn cultures and rates of the most frequently isolated patient-specific isolated organisms/1000 admissions.
Variable/Year | 1990-2000[1] | 2001-2008[1] | ||
Annual Mean ± SD | 11year Total | Annual Mean ± SD | 8Year Total | |
Drawn blood cultures (BC) (n)[2] | 15,779 ± 4787 | 173,571 | 15,070 ± 1047 | 120,565 |
No. of true positive BC (n) | 1609 ± 524 | 17,703 | 1413 ± 125 | 11,308 |
Rate of true positive BC (%) | 10.2 ± 1.5 | 10.2 | 9.4 ± 1.1 | 9.4 |
No. of false positive BC (n) | NA[3] | NA | 1273 ± 132 | 10190 |
Rate of false positive BC (%) | NA | NA | 8.4±1.3 | 8.4 |
Rate/1000 admissions[4] | ||||
Enterobacteriaceae | 12.7±2 | 3394 | 13.2 | 4309 |
E. coli | 5.5±1 | 1494 | 6.4 | 2102 |
S. aureus | 4.7±0.9 | 1240 | 3.3 | 1238 |
K. pneumoniae | 3±0.8 | 779 | 3.3 | 1063 |
Enterococcus spp. | 2.3±0.7 | 631 | 2.9 | 939 |
P. aeruginosa | 1.9±0.5 | 488 | 1.5 | 505 |
S. pneumoniae | 1.7±0.4 | 447 | 2.1 | 681 |
Enterobacter spp. | 1.3±0.5 | 338 | 1.1 | 347 |
Acinetobacter spp. | 1±0.3 | 298 | 1.5 | 482 |
P. mirabilis | 1±0.2 | 260 | 1.4 | 449 |
טבלה 2: Enterobacteriaceae, producing Extended-Spectrum β-lactamases (ESBL) (n,%)2002-2008[5]
טבלה 2א: Collected in the Emergency Department
Year | All Enterobacteriaceae N=2330 (%) | E.coli N=1336 (%)
K.pneumoniae N=341 (%) |
P.mirabilis N=228 (%) | |
2002 | 42/286 (15) | 16/151 (11) | 13/54 (24) | 5/21 (24) |
2003 | 35/322 (11) | 15/191 (8) | 15/47 (32) | 4/28 (14) |
2004 | 41/307 (13) | 17/165 (10) | 8/40 (20) | 9/33 (27) |
2005 | 42/354 (11) | 20/218 (9) | 9/49 (18) | 11/38 (29) |
2006 | 61/319 (19) | 28/198 (14) | 17/37 (46) | 7/32 (22) |
2007 | 84/348 (24) | 46/190 (24) | 10/44 (23) | 19/33 (58) |
2008 | 79/357 (22) | 40/208 (19) | 18/59 (30) | 10/37 (27) |
Total | 393/2330 (16) | 185/1336 (14) | 92/341 (27) | 67/228 (29) |
טבלה 2ב': Collected from hospitalized patients
Year | All Enterobacteriaceae N=1562 (%) | E.coli N=347 (%) | K.pneumoniae N=495 (%) | P.mirabilis N=143 (%) |
2002 | 54/147 (37) | 7/35 (20) | 34/53 (64) | 2/6 (33) |
2003 | 62/213 (29) | 10/46 (22) | 22/55 (40) | 13/26 (50) |
2004 | 64/183 (35) | 11/48 (23) | 28/51 (55) | 10/18 (56) |
2005 | 93/234 (40) | 22/58 (38) | 35/68 (51) | 17/30 (57) |
2006 | 97/267 (36) | 13/54 (24) | 54/86 (63) | 15/29 (52) |
2007 | 58/244 (24) | 12/44 (27) | 35/99 (35) | 7/14 (50) |
2008 | 75/243 (31) | 13/57 (23) | 29/77 (37) | 4/16 (25) |
Total | 512/1562 (33) | 88/347 (25) | 239/495 (48) | 70/143 (49) |
טבלה 3: Enterobacteriaceae – antimicrobial susceptibilities (%) 2001-2008. Breakdown by source of patient
- מקרא
- Amp-Ampicillin;
- Amk-Amikacin;
- Aug-Amoxycillin-clavulanate,
- Carbap-Carbapenems;
- Caz-Ceftazidime;
- Cef-Cefazolin;
- Chl-Chloramphenicol;
- Cip-Ciprofloxacin;
- Col-colistin (polymyxin-B);
- Cpm,-Cefepime,
- Cro-Ceftriaxone;
- Cxm-Cefuroxime;
- Ert-Ertapenem (since 2005);
- Gen-Gentamicin;
- Imp-Imipenem;
- Mez-Mezlocillin (up to mid-2006);
- Meth-Methicillin; Sep-Cotrimoxazole;
- Tob-Tobramycin;
- Tzp-Piperacillin-Tazobactam;
- Van-Vancomycin.
Group | n | Penicillins | Carbap.[6] | Cephalosporins | Aminogly. | Other | |||||||||||
Aug | Mez | Tzp | Ert | Imp | Cef | Cxm | Cro | Caz | Cpm | Gen | Amk | Chl | Sep | Cip | Col | ||
≤48hr | 3447 | 66 | 49 | 91 | 99 | 99 | 61 | 75 | 83 | 85 | 85 | 83 | 97 | 79 | 62 | 73 | 86 |
>48hr | 1898 | 39 | 42 | 76 | 92 | 98 | 32 | 47 | 60 | 62 | 67 | 66 | 89 | 58 | 52 | 59 | 78 |
טבלה 4
Table 4a: Antimicrobial susceptibilities (%) of selected organisms (in alphabetical order), isolated from blood cultures, 2001-2008.
Organism | n | Amp | Amk | Aug | Caz | Cef | Chl | Cip | Col | Cpm | Cxm | Ert | Gen | Imp | Mez | Sep | Tzp | |
Acinetobacter baumanii | 589 | 44 | 13 | 9 | 98 | 24 | 62 | 17 | 19 | |||||||||
Citrobacter species | 189 | 15 | 97 | 74 | 85 | 74 | 85 | 91 | 100 | 87 | 86 | 82 | 100 | 94 | 100 | 84 | 81 | 94 |
E. coli | 2753 | 34 | 98 | 68 | 86 | 64 | 86 | 74 | 100 | 86 | 84 | 79 | 100 | 83 | 100 | 37 | 61 | 93 |
189 | 15 | 97 | 74 | 85 | 74 | 91 | 100 | 87 | 86 | 82 | 99 | 94 | 100 | 84 | 81 | 94 | ||
Enterococcus faecalis# | 410 | 95
Klebsiella oxytoca 119 98 87 93 86 92 94 99 93 91 90 94 100 81 89 94 Klebsiella pneumoniae 1161 81 51 54 44 52 53 99 57 52 49 85 61 95 43 48 60 Morganella morganii 109 95 11 78 6 49 56 91 83 17 60 99 69 48 94 Proteus mirabilis 569 25 98 66 73 44 42 48 67 66 61 99 63 99 41 37 98 Pseudomonas aeruginosa 691 93 91 71 100 92 83 89 76 91 Salmonella* 108 97 100 98 73 100 Serratia marcescens 164 98 85 78 89 86 88 4 100 88 99 88 73 93 S. aureus ** 1646 Steno- trophomonas 156 79 89 82 86 78 88 90 90 Streptococcus pneumoniae* ** הערות שוליים
ביבליוגרפיה
ראו גם |